Genomes, Diseases and Precision Medicine
A National Project
DOI:
https://doi.org/10.24215/26183188e019Keywords:
Precision Medicine, Genomics, Human Populations, HealthAbstract
Precision medicine is presented in the central countries as a new paradigm in the treatment of some diseases. Based on the knowledge of the genome of each individual, it is based on the principle that the success in the treatment of diseases, and the response to drugs, depends on the detailed knowledge of the genetic variants of the individuals, the percentages of ancestry, of the environment and other factors that can not be directly extrapolated among populations. Our country must decide whether to take this knowledge from other countries to apply it in an unspecified way, or launch a national project to benefit our population inclusively with the advances of biomedicine and health in the 21st century.
Downloads
Metrics
Published
How to Cite
Issue
Section
License
The authors whose texts are published in this Journal surrender their ownership rights in favour of the editor in a non exclusive manner, i.e. the authors can enter into other independent and additional contracts to publish their text, e.g. including it in an institutional repository, thematic or otherwise, publish it in a book, or others, as long as it is overtly stated that the work was first published in this Journal.
The responsibility for each published paper as regards its content relies exclusively on its authors, holding the editors harmless for any legal liabilities.
The texts of the Journal shall be published under the Creative Commons 4.0 BY-NC-SA license. Therefore, the editors are free to:
1) Share, copy and redistribute the material using any means or format.
2) Adapt, remix, transform and create from the material, under the following conditions:
a) Attribution — credit to this work must be given in an appropriate manner, providing a link to the license and indicating if changes have been made.
b) Non-Commercial Use — no use may be made of the published material for commercial purposes.
c) Share Equal — Authors remixing, transforming or creating from the material must distribute their contribution under the same license as the original.
